UCP2 and T-cell acute lymphoblastic leukemia: In T-cell acute lymphoblastic leukemia (T-ALL) cell line HPB-ALL, glutamine upregulates UCP2, and UCP2 silencing leads to TCA intermediate accumulation in the matrix, reducing OCR and cell proliferation rates [157].